M Carrabba

1.2k total citations
37 papers, 893 citations indexed

About

M Carrabba is a scholar working on Rheumatology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, M Carrabba has authored 37 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 9 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in M Carrabba's work include Systemic Lupus Erythematosus Research (10 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). M Carrabba is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). M Carrabba collaborates with scholars based in Italy, Israel and Germany. M Carrabba's co-authors include Piercarlo Sarzi‐Puttini, Fabiola Atzeni, Andrea Doria, F. Capsoni, E. Paresce, Simona de Portu, Dan Buskila, M. Turiel, Benedetta Panni and Arnaldo Andreoli and has published in prestigious journals such as Journal of Psychosomatic Research, Alimentary Pharmacology & Therapeutics and Biomedicine & Pharmacotherapy.

In The Last Decade

M Carrabba

36 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Carrabba Italy 15 323 267 238 112 78 37 893
J. K. van der Korst Netherlands 20 469 1.5× 179 0.7× 177 0.7× 52 0.5× 64 0.8× 59 1.1k
İbrahim Tekeoğlu Türkiye 19 462 1.4× 231 0.9× 234 1.0× 192 1.7× 27 0.3× 74 1.2k
Aryeh M. Abeles United States 14 249 0.8× 260 1.0× 204 0.9× 183 1.6× 30 0.4× 20 964
William S. Wilke United States 21 418 1.3× 267 1.0× 157 0.7× 90 0.8× 22 0.3× 64 1.0k
Erik Kåss Norway 15 317 1.0× 372 1.4× 291 1.2× 219 2.0× 37 0.5× 55 1.0k
Alberto Batticciotto Italy 22 555 1.7× 315 1.2× 169 0.7× 385 3.4× 102 1.3× 66 1.3k
Khaled Al‐Jarallah Kuwait 16 223 0.7× 89 0.3× 157 0.7× 63 0.6× 42 0.5× 37 799
M. Cazzola Italy 18 280 0.9× 371 1.4× 256 1.1× 78 0.7× 22 0.3× 38 805
Edward J. Pisko United States 14 266 0.8× 96 0.4× 154 0.6× 101 0.9× 32 0.4× 34 700
David S. Hallegua United States 11 276 0.9× 299 1.1× 130 0.5× 139 1.2× 18 0.2× 14 706

Countries citing papers authored by M Carrabba

Since Specialization
Citations

This map shows the geographic impact of M Carrabba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Carrabba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Carrabba more than expected).

Fields of papers citing papers by M Carrabba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Carrabba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Carrabba. The network helps show where M Carrabba may publish in the future.

Co-authorship network of co-authors of M Carrabba

This figure shows the co-authorship network connecting the top 25 collaborators of M Carrabba. A scholar is included among the top collaborators of M Carrabba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Carrabba. M Carrabba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atzeni, Fabiola, et al.. (2011). Drug-induced lupus erythematosus. Reumatismo. 55(3). 147–54. 3 indexed citations
2.
Sarzi‐Puttini, Piercarlo, Fabiola Atzeni, Manuela Di Franco, et al.. (2008). Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity. 41(1). 74–79. 9 indexed citations
3.
Atzeni, Fabiola, Andrea Doria, Anna Ghirardello, et al.. (2008). Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value. Autoimmunity. 41(1). 111–115. 50 indexed citations
4.
Atzeni, Fabiola, Andrea Doria, Anna Ghirardello, et al.. (2008). Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: A prospective long-term follow-up. Autoimmunity. 41(1). 87–91. 13 indexed citations
5.
Atzeni, Fabiola, et al.. (2008). In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones.. PubMed. 26(1). 103–8. 12 indexed citations
6.
Sarzi‐Puttini, Piercarlo, Dan Buskila, M Carrabba, Andrea Doria, & Fabiola Atzeni. (2007). Treatment Strategy in Fibromyalgia Syndrome: Where Are We Now?. Seminars in Arthritis and Rheumatism. 37(6). 353–365. 79 indexed citations
7.
Atzeni, Fabiola, Andrea Doria, M Carrabba, Maurizio Turiel, & Piercarlo Sarzi‐Puttini. (2007). Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmunity Reviews. 6(8). 529–536. 42 indexed citations
8.
Atzeni, Fabiola, Sandro Ardizzone, Piercarlo Sarzi‐Puttini, et al.. (2005). Autoantibody profile during short‐term infliximab treatment for Crohn's disease: a prospective cohort study. Alimentary Pharmacology & Therapeutics. 22(5). 453–461. 29 indexed citations
10.
Capsoni, F., Piercarlo Sarzi‐Puttini, Fabiola Atzeni, et al.. (2005). Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Research & Therapy. 7(2). R250–5. 33 indexed citations
11.
Sarzi‐Puttini, Piercarlo, Fabiola Atzeni, Maurizio Turiel, et al.. (2004). The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms. Journal of Psychosomatic Research. 56(2). 213–216. 8 indexed citations
12.
Carrabba, M & Piercarlo Sarzi‐Puttini. (2004). Introduction: Osteoarthritis in the Third Millennium: A New Era for an Old Disease?. Seminars in Arthritis and Rheumatism. 34(6). 1–2. 3 indexed citations
13.
Sarzi‐Puttini, Piercarlo, Sandro Ardizzone, G. Manzionna, et al.. (2003). Infliximab-induced lupus in Crohn’s disease: a case report. Digestive and Liver Disease. 35(11). 814–817. 49 indexed citations
14.
Cortelezzi, Agostino, Nicola Stefano Fracchiolla, Marina Motta, et al.. (2001). Hyperhomocysteinemia in Myelodysplastic Syndromes: Specific Association with Autoimmunity and Cardiovascular Disease. Leukemia & lymphoma. 41(1-2). 147–150. 8 indexed citations
15.
Carrabba, M, et al.. (1995). The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. 15(1). 25–31. 70 indexed citations
18.
Galanti, Andrea, et al.. (1993). Efficacy and tolerability of galactosamino-glycuronoglycan-sulfate in osteoarthritis of the knee: an 11-month experience.. PubMed. 13 Suppl. 49–53. 4 indexed citations
19.
Mele, Giuseppina, et al.. (1987). The coexistence of rheumatoid arthritis and systemic lupus erythematosus. Clinical Rheumatology. 6(3). 439–445. 5 indexed citations
20.
Carrabba, M, et al.. (1982). [Acupuncture in rheumatology. Case contribution].. PubMed. 73(30-31). 2031–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026